COVID activity in the United States continues to decline, and seasonal flu markers show no upticks, according to the latest respiratory disease updates today from the US Centers for Disease Control and Prevention.
As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen COVID-19/flu combination test outside of emergency use authorization.
A GP has explained the symptoms of the newest strain of Covid saying they are different from those caused by earlier variants and are leaving people 'wiped out'. The XEC variant of Covid has rapidly become dominant having spread to hundreds of countries around the world.
Recent Comments